Soleno
Highly Engaged Employees
Manufacturing · Canada · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1160 Rte 133, Iberville, Quebec, J2X 4J5...Phone Number
(450) 347-7855Website
www.soleno.comRevenue
$55.3 MillionIndustry
About Soleno
Soleno Org Chart
Is Soleno your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Soleno launches new products
Check if Soleno has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Soleno recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Soleno
Click to see if Soleno had a recent Job posting/layoffs
Check out if Soleno is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Soleno has new funding data
Soleno, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Soleno is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Soleno is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Soleno.
Soleno Tech Stack
A closer look at the technologies used by Soleno
Soleno News & Media
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
BALA CYNWYD, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.SOLENO THERAPEUTICS CLASS ACTION DEADLINE TOMORROW: Bragar Eagel & Squire, P.C. Urges Soleno Therapeutics, Inc. Investors with Significant Losses to Contact the Firm Before May 5th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Soleno (SLNO) To Contact Him Directly To Discuss Their OptionsBragar Eagel & Squire, P.C. Urges Soleno Therapeutics, Inc. Investors with Significant Losses to Contact the Firm Before May 5th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Soleno (SLNO) To Contact Him Directly To Discuss Their OptionsDeadline Alert: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2026, inclusive (the “Class Period”).
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Soleno
Under our roads, our neighborhoods, our houses and our fields, Soleno is present everywhere. The leading developer of sustainable solutions, we are masters in rainwater management for the infrastructure, residential, natural resources and agricultural development sectors.... Read More